ISSN 2410-7751 (Print)
ISSN 2410-776X (Online)
Biotechnologia Acta Т. 16, No. 2 , 2023
P 7-10., Bibliography 10, Engl.
UDC: 577.29
DOI: https://doi.org/10.15407/biotech16.02.007
Full text: (PDF, in English)
SYNTHESIS OF CALIX[4]ARENES WITH FIXED CONFORMATION AS POTENTIAL INHIBITORS OF FIBRIN POLYMERIZATION
D.M. Ahishev 1, 2, 3, O.O. Hrabovskyi 1
1Palladin Institute of Biochemistry of the National Academy of Sciences of Ukraine, Kyiv;
2 Institute of Organic Chemistry of the National Academy of Sciences of Ukraine, Kyiv;
3 Kyiv National Taras Shevchenko University, Ukraine
Aim. The purpose of the present study was to develop a method for the fixation of ‘fixed’ conformation for estimation of the impact of calix[4]arene structure on the efficacy of its anticoagulant activity. This was achieved by substitution of the lower rim of C-145 analogue.
Methods.Calix[4]arene C-145F (compound 6) was obtained in 4 steps starting with Duff reaction. Calix[4]arene methylene-bis-phosphonic ester 3 was prepared via addition of diisopropylphosphite in presence of metallic sodium to the parent calix[4]arene aldehyde 2. Further steps included Mitsunobu reaction, that afforded dipropoxycalix[4]arene 5 with rather good yields (80%), following the hydrolysis step that resulted in compound 6 in almost quantitative yield.
Modeling of 3D-structure of calix[4]arene C-145 and its analogue C-145F was performed in Maestro, Schrodinger software.
Results. Using a 2D NMR-NOESY spectroscopy, we can observe a distinct cross-peak between an aromatic singlet with a chemical shift on 7.72 ppm and protons of isopropyl group with a chemical shift on 1.62 ppm, which are moved in the strong field.
Conclusions. The easy method of the fixation of conus conformation of calix[4]arene cup will be useful for synthesis of novel functionally active compounds. We believe that further development and study of different calix[4]arenes will help scientists to obtain bioactive molecules that could be prospective anti-thrombotic drugs.
Key words: calix[4]arene, fibrin polymerization, organic synthesis, bioinformatics.
© Palladin Institute of Biochemistry of National Academy of Sciences of Ukraine, 2023
References
...1. Aaron M. Wendelboe, Gary E. Raskob . Global Burden of Thrombosis Epidemiologic Aspects. Circulation Research. 2016, 118(9), 1340-1347. https://doi.org/10.1161/CIRCRESAHA.115.306841
2. SIXTY-SIXTH WORLD HEALTH ASSEMBLY. A/RES/66/2. 27 May 2013
3. Rajesh Kumar, Amit Sharma, Hardev Singh, Paolo Suating, Hyeong Seok Kim, Kyoung Sunwoo, Inseob Shim, Bruce C. Gibb, Jong Seung Kim. Revisiting Fluorescent Calixarenes: From Molecular Sensors to Smart Materials. Chem. Rev. 2019, 119(16), 9657–9721. https://doi.org/10.1021/acs.chemrev.8b00605
4. Didkivskyi V., Pavlenko A. Aprobation of calix[4]arene C-145 as antitrombotic agent in vivo. Biotechnologia acta. 2022, 15(5), 41–46. https://doi.org/10.15407/biotech15.05.041
5. Didkivskyi V.A., Pavlenko A.O., Marunych R.Y., Selikhova A.O., Cherenok S.O., T.P. Todosiuk., Shevchenko S.M. HPLC detection of antithrombitic calix[4]arene in blood plasma of animals. Biotechnologia Acta 2022, 15(2), 51–52. https://doi.org/10.15407/biotech15.02.051
6. Lugovskoy E.V., Gritsenko P.G., Koshel T.A., Koliesnik I.O., Cherenok S.O., Kalchenko O.I., Kalchenko V.I., Komisarenko S.V. Calix[4]arene methylenebisphosphonic acids as inhibitors of fibrin polymerization. FEBS J. 2011, 278(8), 1244–1251. https://doi.org/10.1111/j.1742-4658.2011.08045.x